Abologix
Geneva, CH · 1 known investors
Abologix is a biopharmaceutical company developing two monoclonal antibodies that target JAM-C and Olfactomedin-like protein 3 (Olfml3) for oncology indications. It is a spin-out from the University of Geneva and Geneva University Hospitals.
BiotechHealthtech
Founders & leadership
IF
Ignacio FausFounder
BI
Beat ImhofFounder
TM
Thomas MatthesFounder
Investors · 1
Frequently asked questions
- What does Abologix do?
- Abologix is a biopharmaceutical company developing two monoclonal antibodies that target JAM-C and Olfactomedin-like protein 3 (Olfml3) for oncology indications. It is a spin-out from the University of Geneva and Geneva University Hospitals.
- Who founded Abologix?
- Abologix was founded by Ignacio Faus, Beat Imhof, Thomas Matthes.
- Who are Abologix's investors?
- Abologix's investors include Kickfund.
- Where is Abologix headquartered?
- Abologix is headquartered in Geneva, CH.